GS-5734
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-5734, covering 2022-02-15 to 2022-02-15. Get the full timeline:
Most recent: Clinical Trial Update: GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen [Phase 2]